Published in BMJ on January 06, 2001
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart (2005) 9.79
Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med (2004) 5.97
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med (2007) 5.95
A meta-analysis of interventions to improve care for chronic illnesses. Am J Manag Care (2005) 5.10
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol (2006) 4.02
Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol (2012) 3.91
Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 3.76
Hypoglycaemia in Type 2 diabetes. Diabet Med (2008) 3.00
Depression in adolescence. Lancet (2012) 2.74
Racial and Ethnic Approaches to Community Health (REACH) Detroit partnership: improving diabetes-related outcomes among African American and Latino adults. Am J Public Health (2005) 2.11
The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care (2015) 1.93
PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J Clin Invest (2001) 1.82
Changes in BMI, duration of overweight and obesity, and glucose metabolism: 45 years of follow-up of a birth cohort. Diabetes Care (2011) 1.71
Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One (2012) 1.57
Social circumstances and education: life course origins of social inequalities in metabolic risk in a prospective national birth cohort. Am J Public Health (2006) 1.53
Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia (2010) 1.49
Dementia before death in ageing societies--the promise of prevention and the reality. PLoS Med (2006) 1.34
Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes. Circ Cardiovasc Qual Outcomes (2010) 1.33
Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem (2009) 1.30
Physical activity in obesity and metabolic syndrome. Ann N Y Acad Sci (2012) 1.16
The future of laboratory medicine: understanding the new pressures. Clin Biochem Rev (2004) 1.16
Depression, diabetes, and glycemic control in an American Indian community. J Clin Psychiatry (2008) 1.11
Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults. Diabet Med (2007) 1.11
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
Changes in glycemic control are associated with changes in cognition in non-diabetic elderly. J Alzheimers Dis (2012) 1.10
Outcomes from a diabetes self-management intervention for Native Hawaiians and Pacific People: Partners in Care. Ann Behav Med (2013) 1.09
Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench. in streptozotocin-induced diabetic rats. J Pharm Bioallied Sci (2011) 1.05
Associations between socioeconomic status and allostatic load: effects of neighborhood poverty and tests of mediating pathways. Am J Public Health (2012) 1.05
Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. Wien Med Wochenschr (2010) 1.05
The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol (2008) 1.02
Healthy lifestyle choices: could sense of coherence aid health promotion? J Epidemiol Community Health (2007) 1.02
Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function. PLoS One (2011) 1.02
Prediabetes as a therapeutic target. Clin Chem (2010) 1.01
Redefining the diagnosis of diabetes using glycated hemoglobin. Diabetes Care (2009) 1.00
Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet (2012) 0.99
Ethnic and social disparity in glycaemic control in type 2 diabetes; cohort study in general practice 2004-9. J R Soc Med (2012) 0.99
No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population. Diabetologia (2011) 0.99
Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study. Cardiovasc Diabetol (2012) 0.98
The median is not the only message: a clinician's perspective on mathematical analysis of glycemic variability and modeling in diabetes mellitus. J Diabetes Sci Technol (2009) 0.97
An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health (2008) 0.95
Implications of postprandial glucose and weight control in people with type 2 diabetes: understanding and implementing the International Diabetes Federation guidelines. Diabetes Care (2009) 0.95
Resistance exercise training lowers HbA1c more than aerobic training in adults with type 2 diabetes. Diabetol Metab Syndr (2009) 0.95
Predicting mortality with biomarkers: a population-based prospective cohort study for elderly Costa Ricans. Popul Health Metr (2012) 0.95
Relationships of cotinine and self-reported cigarette smoking with hemoglobin A1c in the U.S.: results from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care (2011) 0.93
Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot study. Diabetes Care (2008) 0.93
Association between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D study. Mayo Clin Proc (2010) 0.92
G6PC2: a negative regulator of basal glucose-stimulated insulin secretion. Diabetes (2012) 0.92
Gender-specific epidemiology of diabetes: a representative cross-sectional study. Int J Equity Health (2009) 0.91
Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels. Diabetologia (2013) 0.91
Should A1C targets be individualized for all people with diabetes? Arguments for and against. Diabetes Care (2011) 0.91
A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes. Osteopath Med Prim Care (2007) 0.90
A well-being programme in severe mental illness. Baseline findings in a UK cohort. Int J Clin Pract (2007) 0.90
Prolonged Nightly Fasting and Breast Cancer Risk: Findings from NHANES (2009-2010). Cancer Epidemiol Biomarkers Prev (2015) 0.90
Glycemic control and cardiovascular disease: what's a doctor to do? Curr Diab Rep (2012) 0.89
Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care (2012) 0.89
Childhood cognition and risk factors for cardiovascular disease in midadulthood: the 1958 British Birth Cohort Study. Am J Public Health (2010) 0.88
Three 15-min bouts of moderate postmeal walking significantly improves 24-h glycemic control in older people at risk for impaired glucose tolerance. Diabetes Care (2013) 0.87
HbA1c and the risks for all-cause and cardiovascular mortality in the general Japanese population: NIPPON DATA90. Diabetes Care (2013) 0.87
Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach. Am J Epidemiol (2010) 0.87
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes. Diabetes Care (2009) 0.86
Prediction model for high glycated hemoglobin concentration among ethnic Chinese in Taiwan. Cardiovasc Diabetol (2010) 0.86
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes. Vasc Health Risk Manag (2006) 0.83
"Normal" blood glucose and coronary risk. BMJ (2001) 0.83
Relation of glycated hemoglobin with carotid atherosclerosis in ischemic stroke patients: An observational study in Indian population. Ann Indian Acad Neurol (2013) 0.83
PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort. Cardiovasc Diabetol (2014) 0.82
HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus. PLoS One (2012) 0.82
Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. World J Cardiol (2014) 0.82
The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies. Rev Diabet Stud (2014) 0.82
Hemoglobin a1c is positively correlated with framingham risk score in older, apparently healthy nondiabetic korean adults. Endocrinol Metab (Seoul) (2013) 0.81
A review of nateglinide in the management of patients with type 2 diabetes. Vasc Health Risk Manag (2007) 0.81
Evaluation of serum zinc status and glycated hemoglobin of type 2 diabetes mellitus patients in a tertiary care hospital of assam. J Lab Physicians (2013) 0.81
Cardiovascular disease, neuropathy, and retinopathy. Diabetes Care (2009) 0.81
Association between adolescent emotional problems and metabolic syndrome: the modifying effect of C-reactive protein gene (CRP) polymorphisms. Brain Behav Immun (2011) 0.81
Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention. Cardiovasc Diabetol (2015) 0.80
Topics in type 2 diabetes and insulin resistance. Diabetes Care (2009) 0.80
Is hyperglycemia a cardiovascular risk factor? Diabetes Care (2011) 0.80
Diabetes and biomarkers. J Diabetes Sci Technol (2011) 0.80
Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Am Heart Assoc (2015) 0.80
Diagnosed diabetes and premature death among middle-aged Japanese: results from a large-scale population-based cohort study in Japan (JPHC study). BMJ Open (2015) 0.80
Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys. Cardiovasc Diabetol (2004) 0.79
Hemoglobin A1c as a diagnostic tool: public health implications from an actor-network perspective. Am J Public Health (2011) 0.79
Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction. PLoS One (2012) 0.79
Diabetes, periodontitis, and the subgingival microbiota. J Oral Microbiol (2010) 0.79
Diet and glycosylated haemoglobin in the 1946 British birth cohort. Eur J Clin Nutr (2009) 0.78
Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients. Vasc Health Risk Manag (2008) 0.78
Tailoring treatment to risk in type 2 diabetes. Br J Gen Pract (2010) 0.78
Risk factors for myocardial infarction among low socioeconomic status South Indian population. Diabetol Metab Syndr (2010) 0.78
Modifiable causes of premature death in middle-age in Western Europe: results from the EPIC cohort study. BMC Med (2016) 0.78
Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucose. PLoS One (2017) 0.78
A literature review of the cardiovascular risk-assessment tools: applicability among Asian population. Heart Asia (2010) 0.77
New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs. J Natl Med Assoc (2007) 0.77
Is it possible to reduce cardiovascular risk with glucose-lowering approaches? Nat Rev Endocrinol (2009) 0.77
Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications. Age (Dordr) (2008) 0.77
Type of β-blocker use among patients with versus without diabetes after myocardial infarction. Am Heart J (2014) 0.76
Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights (2016) 0.76
Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications. Biomed Res Int (2014) 0.76
Hemoglobin A1c Level Is Not Related to the Severity of Atherosclerosis in Patients with Acute Coronary Syndrome. Dis Markers (2015) 0.76
[Diabetics in secondary prevention]. Clin Res Cardiol (2006) 0.75
Diabetes: Low HbA1c levels and mortality in type 2 diabetes mellitus. Nat Rev Endocrinol (2010) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (1997) 49.11
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes (1979) 12.35
Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) (1981) 11.00
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer (1999) 9.68
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care (1999) 9.16
The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes (1995) 8.89
The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med (1997) 7.65
Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ (1994) 5.22
The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes (1996) 5.09
Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J (1998) 5.09
Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet (1980) 4.86
Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med (1992) 3.81
Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med (1995) 3.76
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia (1999) 3.60
Standardization of HbA1c measurements--a consensus statement. Diabet Med (2000) 2.54
Lilly Lecture 1993. Glycation and diabetic complications. Diabetes (1994) 1.92
GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care (1996) 1.90
Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. The Atherosclerosis Risk in Communities Study. Diabetes Care (1997) 1.73
Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet (1999) 1.73
Mortality from coronary heart disease in the Tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol (1985) 1.66
Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl (1985) 1.63
Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev (1992) 1.63
Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl (1985) 1.52
Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes (1987) 1.45
Glucose intolerance and physical inactivity: the relative importance of low habitual energy expenditure and cardiorespiratory fitness. Am J Epidemiol (2000) 1.41
Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes (1992) 1.36
The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med (1994) 1.36
Screening for type 2 diabetes. Diabetes Care (2000) 1.33
Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia (1999) 1.33
Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care (2000) 1.28
Glucose: a continuous risk factor for cardiovascular disease. Diabet Med (1997) 1.15
Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol (1991) 1.14
Frequent salad vegetable consumption is associated with a reduction in the risk of diabetes mellitus. J Clin Epidemiol (1999) 1.14
Fasting blood glucose and risk of coronary heart disease, stroke, and all-cause mortality: a 17-year follow-up study of men born in 1913. Diabet Med (1986) 1.07
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer (1999) 9.68
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (2000) 7.66
Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol (2001) 4.94
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer (2000) 3.49
Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr (1994) 3.25
Evaluation of the effectiveness of an educational intervention for general practitioners in adolescent health care: randomised controlled trial. BMJ (2000) 3.24
Retrospective study of reasons for improved survival in patients with breast cancer in east Anglia: earlier diagnosis or better treatment. BMJ (1997) 3.18
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Dietary fibre in the British diet. Nature (1978) 2.97
Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ (1995) 2.96
Traumatic grief as a risk factor for mental and physical morbidity. Am J Psychiatry (1997) 2.80
Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. Eur J Clin Nutr (2003) 2.68
Residential area deprivation predicts smoking habit independently of individual educational level and occupational social class. A cross sectional study in the Norfolk cohort of the European Investigation into Cancer (EPIC-Norfolk). J Epidemiol Community Health (2003) 2.66
Intakes and sources of dietary fiber in the British population. Am J Clin Nutr (1979) 2.58
An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol Cell Biol (1999) 2.57
Screening for cancer of the uterine cervix in Iceland 1965--1978. Acta Obstet Gynecol Scand (1982) 2.57
Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2009) 2.51
The effect of mass screening in Iceland, 1965-74, on the incidence and mortality of cervical carcinoma. Int J Cancer (1978) 2.34
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Dietary assessment in Whitehall II: comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers. Br J Nutr (2001) 2.32
Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol (1999) 2.29
Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr (2001) 2.21
The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21
Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study. Aliment Pharmacol Ther (2011) 2.12
Comparing hypertension guidelines. Guidelines are based on evidence from trials, not normal practice. BMJ (1996) 2.08
Validation of weighed records and other methods of dietary assessment using the 24 h urine nitrogen technique and other biological markers. Br J Nutr (1995) 2.07
Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg (1995) 2.03
Trajectories of alcohol consumption following liver transplantation. Am J Transplant (2010) 2.01
Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease. Aliment Pharmacol Ther (2014) 2.00
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia (2009) 1.96
Association between age at menarche and risk of diabetes in adults: results from the EPIC-Norfolk cohort study. Diabetologia (2008) 1.92
Standardization of the 24-hour diet recall calibration method used in the european prospective investigation into cancer and nutrition (EPIC): general concepts and preliminary results. Eur J Clin Nutr (2000) 1.92
Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia (2012) 1.87
Dose-dependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis (2001) 1.70
Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. European Prospective Investigation into Cancer and Nutrition. Comput Methods Programs Biomed (1999) 1.68
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. Clin Pharmacol Ther (2007) 1.67
Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol (1998) 1.66
The incidence of genetic disease in a University hospital population. Am J Hum Genet (1973) 1.66
Some insights into Miettinen's multivariate confounder score approach to case-control study analysis. Epidemiol Community Health (1979) 1.62
Short-term effects of air pollution on mortality in Athens. Int J Epidemiol (1986) 1.61
Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. Lancet (1978) 1.59
Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia (2007) 1.59
The CAFE computer program for nutritional analysis of the EPIC-Norfolk food frequency questionnaire and identification of extreme nutrient values. J Hum Nutr Diet (2005) 1.59
Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 1.58
Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study. J Epidemiol Community Health (2001) 1.56
The use of 4-aminobenzoic acid as a marker to validate the completeness of 24 h urine collections in man. Clin Sci (Lond) (1983) 1.56
Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol (2001) 1.56
The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol (1990) 1.55
Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet (1997) 1.55
European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer (1993) 1.52
Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics (1982) 1.52
Incremental prognostic value of exercise thallium-201 myocardial single-photon emission computed tomography late after coronary artery bypass surgery. J Am Coll Cardiol (1995) 1.51
Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr (2009) 1.49
DINER (Data Into Nutrients for Epidemiological Research) - a new data-entry program for nutritional analysis in the EPIC-Norfolk cohort and the 7-day diary method. Public Health Nutr (2001) 1.49
Correlated measurement error--implications for nutritional epidemiology. Int J Epidemiol (2004) 1.49
Resistant rheumatoid arthritis clinics- a necessary development? Rheumatology (Oxford) (2000) 1.48
Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47
Britain's first minister of public health. National centre for public health is needed. BMJ (1997) 1.46
Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen (1999) 1.45
Effects of prenatal alcohol exposure on social behavior in humans and other species. Neurotoxicol Teratol (2000) 1.44
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Drowning associated pneumonia: a descriptive cohort. Resuscitation (2011) 1.43
Finding the right RNA: identification of cellular mRNA substrates for RNA-binding proteins. RNA (1999) 1.42
Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen (1998) 1.40